Susan Conroy
Chief Executive Officer Therakind
Seminars
Wednesday 3rd February 2027
The Evolution of Intranasal Drug Delivery: Lessons Learned from Developing the Next Generation of Nasal Products
8:30 am
- Explore how intranasal drug delivery has evolved over the last decade, examining the scientific, regulatory, commercial, and technological developments that are shaping the next generation of nasal therapies
- Understand the critical decisions developers must make when selecting formulations, delivery devices, and development strategies, ensuring both the therapeutic and delivery system are optimized for long-term clinical and commercial success
- Learn lessons from progressing intranasal products through development and regulatory review, identifying common development challenges, unexpected barriers, and opportunities that continue to drive innovation across the nasal delivery landscape
